SIGLEC1 and Parkinson disease: The selective depletion of CD169+ BAMs in our model produced PD-like symptoms without overt directly causing neuronal death, providing a unique platform for dissecting how peripheral immune interfaces influence CNS circuitry in the prodromal phase of neurodegenerative disorders.